Clinical Trial Update: Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating ETC-1002 (bempedoic acid), ezetimibe, and their combination in patients with hypercholesterolemia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• ETC-1002 (bempedoic acid)
• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED